SI0871467T1 - Formulation for peptide release - Google Patents

Formulation for peptide release

Info

Publication number
SI0871467T1
SI0871467T1 SI9630524T SI9630524T SI0871467T1 SI 0871467 T1 SI0871467 T1 SI 0871467T1 SI 9630524 T SI9630524 T SI 9630524T SI 9630524 T SI9630524 T SI 9630524T SI 0871467 T1 SI0871467 T1 SI 0871467T1
Authority
SI
Slovenia
Prior art keywords
formulation
deslorelin
peptide release
mug
testosterone
Prior art date
Application number
SI9630524T
Other languages
English (en)
Slovenian (sl)
Inventor
John Desmond Walsh
Timothy Elliot Trigg
Original Assignee
Peptech Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptech Limited filed Critical Peptech Limited
Publication of SI0871467T1 publication Critical patent/SI0871467T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
SI9630524T 1995-06-20 1996-06-20 Formulation for peptide release SI0871467T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPN3667A AUPN366795A0 (en) 1995-06-20 1995-06-20 Formulation for preventing reproductive function
PCT/AU1996/000370 WO1997000693A1 (en) 1995-06-20 1996-06-20 Novel formulation for peptide release

Publications (1)

Publication Number Publication Date
SI0871467T1 true SI0871467T1 (en) 2003-08-31

Family

ID=3788008

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9630524T SI0871467T1 (en) 1995-06-20 1996-06-20 Formulation for peptide release

Country Status (17)

Country Link
US (2) US5925619A (ja)
EP (1) EP0871467B1 (ja)
JP (1) JP4016133B2 (ja)
CN (1) CN1145496C (ja)
AT (1) ATE223726T1 (ja)
AU (2) AUPN366795A0 (ja)
CA (1) CA2225796C (ja)
DE (2) DE122008000004I2 (ja)
DK (1) DK0871467T3 (ja)
ES (1) ES2182983T3 (ja)
FR (1) FR08C0001I2 (ja)
HK (1) HK1014874A1 (ja)
NL (1) NL300330I2 (ja)
NZ (1) NZ309697A (ja)
PT (1) PT871467E (ja)
SI (1) SI0871467T1 (ja)
WO (1) WO1997000693A1 (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN366795A0 (en) * 1995-06-20 1995-07-13 Peptide Technology Limited Formulation for preventing reproductive function
DK1007080T3 (da) 1996-08-30 2007-07-30 Peptech Ltd Formulering til vedvarende frigivelse af peptidagonister og analoger af GnRH
WO2000004897A1 (en) * 1998-07-20 2000-02-03 Peptech Limited Bioimplant formulation
US8052982B2 (en) * 1998-07-20 2011-11-08 Peptech Animal Health Pty Limited Bioimplant formulation comprising lecithin and stearin
US6211221B1 (en) * 1999-04-05 2001-04-03 Johnny W. Peterson Dietary supplement containing histidine for alleviating dysmenorrhea, endometriosis, and pre-term labor
WO2002036144A1 (en) * 2000-10-30 2002-05-10 University Of Zurich Gnrh analogues for treatment of urinary incontinence
GB0221539D0 (en) * 2002-09-17 2002-10-23 Medical Res Council Methods of treatment
CA2552241C (en) * 2003-12-30 2013-10-01 Durect Corporation Co-polymeric devices for controlled release of active agents
WO2006071208A1 (en) * 2004-12-23 2006-07-06 Durect Corporation Polymeric implants, preferably containing a mixture of peg and plg, for controlled release of a gnrh
RU2010114018A (ru) * 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) Применение пептид тимозина бета 4 индивидуально или в сочетании с цекропином а в качестве терапевтического средства
DE102008015104A1 (de) 2008-03-19 2009-09-24 Basf Coatings Ag Beschichtungszusammensetzung, Verfahren zu ihrer Herstellung, ihre Verwendung und mit ihr beschichtete Substrate

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS563846B2 (ja) * 1972-10-12 1981-01-27
US4218439A (en) * 1977-07-14 1980-08-19 The Salk Institute For Biological Studies Peptide which inhibits gonadal function
US4256737A (en) * 1979-06-11 1981-03-17 Syntex (U.S.A.) Inc. Long acting depot injectable formulations for LH-RH analogues
CA1257199A (en) * 1986-05-20 1989-07-11 Paul Y. Wang Preparation containing bioactive macromolecular substance for multi-months release in vivo
EP0257368B1 (en) * 1986-08-11 1992-03-25 American Cyanamid Company Compositions for parenteral administration and their use
US4897268A (en) * 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
US5538739A (en) * 1989-07-07 1996-07-23 Sandoz Ltd. Sustained release formulations of water soluble peptides
US5211952A (en) * 1991-04-12 1993-05-18 University Of Southern California Contraceptive methods and formulations for use therein
WO1993015722A1 (en) * 1992-02-07 1993-08-19 Syntex (Usa) Inc. Controlled delivery of pharmaceuticals from preformed porous microparticles
AUPN366795A0 (en) * 1995-06-20 1995-07-13 Peptide Technology Limited Formulation for preventing reproductive function

Also Published As

Publication number Publication date
DE69623652D1 (de) 2002-10-17
AU701837B2 (en) 1999-02-04
JP2001521482A (ja) 2001-11-06
FR08C0001I1 (ja) 2008-03-21
NL300330I1 (nl) 2008-03-03
DE122008000004I2 (de) 2009-08-06
EP0871467B1 (en) 2002-09-11
ATE223726T1 (de) 2002-09-15
DE122008000004I1 (de) 2008-04-17
ES2182983T3 (es) 2003-03-16
NZ309697A (en) 1999-11-29
WO1997000693A1 (en) 1997-01-09
US5925619A (en) 1999-07-20
FR08C0001I2 (ja) 2009-11-20
EP0871467A1 (en) 1998-10-21
JP4016133B2 (ja) 2007-12-05
HK1014874A1 (en) 1999-10-08
US6211152B1 (en) 2001-04-03
DE69623652T2 (de) 2003-05-28
CN1145496C (zh) 2004-04-14
DK0871467T3 (da) 2002-12-23
AUPN366795A0 (en) 1995-07-13
CA2225796A1 (en) 1997-01-09
PT871467E (pt) 2002-12-31
NL300330I2 (nl) 2008-04-01
CA2225796C (en) 2011-09-20
AU5992796A (en) 1997-01-22
EP0871467A4 (en) 2000-07-05
CN1188414A (zh) 1998-07-22

Similar Documents

Publication Publication Date Title
FR08C0001I2 (ja)
AU4718496A (en) Use of aerogels in agriculture
AU560829B2 (en) Continuous release pharmaceutical compositions
MY113488A (en) Compounds with growth hormone releasing properties
IL102591A (en) Compositions for the sustained and controlled release of peptide medicaments and their preparation
IL123505A0 (en) Sustained release matrix for high-dose insoluble drugs
GR3026338T3 (en) High release solid preparation, preparation and use thereof
EP1178988A4 (en) THERAPEUTIC COMPOUNDS AND METHODS
UA35611C2 (uk) Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри
EP0663835A1 (en) USE OF PARATHORMONE, ITS BIOLOGICALLY ACTIVE FRAGMENTS AND RELATED PEPTIDES FOR THE TREATMENT OF PREGNANCY PROBLEMS.
HK1038310A1 (en) Compositions and methods for treating intracellular infections.
IL107153A (en) Pharmaceutical compositions for preventing insulin-dependent diabetes mellitus comprising IL10 and method for their manufacture
PL318130A1 (en) Terpenod derivatives (of sarcodictyine)as antineoplastic agents
WO1994020115A3 (en) Hyaluronic acid used as a cancer treatment
OA09771A (en) Asphodelus composition for increasing white blood cell count.
BG51699A1 (en) Stimulating fertility agent
UA36126A (uk) Бандаж поперековий
UA30723A (uk) Спосіб лікування аутоімунних захворювань
UA7163A (uk) Спосіб відновлення ушкоджених тканин людини чи тварини
IT1245148B (it) Glicoproteine estratte da apparati riproduttori femminili, loro uso in dermatologia e cosmesi della pelle e delle mucose
IT1243978B (it) Farmaco per uso umano, ad azione contraccettiva ed oncostatica preventiva, nei tumori del seno, dell'utero e nel melanoma.